KalVista Pharmaceuticals (KALV) EBIT Margin (2014 - 2025)
KalVista Pharmaceuticals recorded quarterly EBIT Margin of 103.52% in Q3 2025, up 79.31% quarter-over-quarter from 500.27% in Q2 2025.
KalVista Pharmaceuticals' EBIT Margin history runs 8 years deep, the most recent figure standing at 103.52% for Q3 2025.
- In Q3 2025, EBIT Margin changed N/A year-over-year to 103.52%; the TTM figure through Jul 2025 stood at 284.12% (up 138488.0% YoY), while the FY2025 annual figure was 1709.05%, down 142816.0% from the prior year.
- EBIT Margin came in at 103.52% for Q3 2025 at KalVista Pharmaceuticals, up from 500.27% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 103.52% in Q3 2025 to a low of 500.27% in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 17.83% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.02% |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn | -103.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -103.52% |
| Apr 30, 2025 | -500.27% |
| Apr 30, 2020 | -234.23% |
| Jan 31, 2020 | -806.85% |
| Oct 31, 2019 | -236.96% |
| Jul 31, 2019 | -283.88% |
| Apr 30, 2019 | -384.83% |
| Jan 31, 2019 | -171.21% |
| Oct 31, 2018 | -87.50% |
| Jul 31, 2018 | -188.52% |
| Apr 30, 2018 | -61.34% |
| Jan 31, 2018 | -186.44% |
| Oct 31, 2017 | -526.80% |
| Jul 31, 2017 | -5,680.21% |
| Apr 30, 2017 | -4,461.40% |
| Jan 31, 2017 | -3,272.98% |
| Oct 31, 2016 | -2,043.15% |
| Jul 31, 2016 | -525.13% |
| Mar 31, 2016 | -93,257.14% |
| Dec 31, 2015 | -79,557.14% |
| Sep 30, 2015 | -69,985.71% |
| Jun 30, 2015 | -80,957.14% |
| Mar 31, 2015 | -70,014.29% |
| Sep 30, 2014 | -35,680.00% |
| Jun 30, 2014 | -48,720.00% |
| Mar 31, 2014 | -30,933.33% |